nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACE inhibitors in patients with vascular disease: Should the peace trial change medical practice?
|
Carey, Robert M. |
|
2005 |
7 |
2 |
p. 119-120 |
artikel |
2 |
Advanced-glycation end products in insulin-resistant states
|
Soldatos, Georgia |
|
2005 |
7 |
2 |
p. 96-102 |
artikel |
3 |
BENEDICT in the treatment of hypertension
|
Logan, Alexander |
|
2005 |
7 |
2 |
p. 121-123 |
artikel |
4 |
Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species
|
Whiteside, Catharine I. |
|
2005 |
7 |
2 |
p. 148-154 |
artikel |
5 |
Is angiotensin II made inside or outside of the cell?
|
Chai, Wenxia |
|
2005 |
7 |
2 |
p. 124-127 |
artikel |
6 |
Metabolic syndrome and endothelial dysfunction
|
Fornoni, Alessia |
|
2005 |
7 |
2 |
p. 88-95 |
artikel |
7 |
Metabolic syndrome therapy: Prevention of vascular injury by antidiabetic agents
|
Dominguez, Ligia J. |
|
2005 |
7 |
2 |
p. 110-116 |
artikel |
8 |
Molecular evidence of tissue renin-angiotensin systems: A focus on the brain
|
Sakai, Koji |
|
2005 |
7 |
2 |
p. 135-140 |
artikel |
9 |
Molecular evidence of tissue renin-angiotensin systems: A focus on the brain
|
Sakai, Koji |
|
|
7 |
2 |
p. 135-140 |
artikel |
10 |
Pathophysiology and clinical meaning of small resistance artery remodeling
|
Rosei, Enrico Agabiti |
|
2005 |
7 |
2 |
p. 79-80 |
artikel |
11 |
Role of angiotensin III in hypertension
|
Reaux-Le Goazigo, Annabelle |
|
2005 |
7 |
2 |
p. 128-134 |
artikel |
12 |
The metabolic effects of angiotensin-receptor blockers
|
Tuck, Michael L. |
|
2005 |
7 |
2 |
p. 85-87 |
artikel |
13 |
The metabolic syndrome in the Asian population
|
Rakugi, Hiromi |
|
2005 |
7 |
2 |
p. 103-109 |
artikel |
14 |
The salt paradox and its possible implications in managing hypertensive diabetic patients
|
Vallon, Volker |
|
2005 |
7 |
2 |
p. 141-147 |
artikel |
15 |
Web alert
|
|
|
2005 |
7 |
2 |
p. 81-82 |
artikel |